Literature DB >> 22232594

Increased capillaries in mitochondrial myopathy: implications for the regulation of oxygen delivery.

Tanja Taivassalo1, Karen Ayyad, Ronald G Haller.   

Abstract

Human skeletal muscle respiratory chain defects restrict the ability of working muscle to extract oxygen from blood, and result in a hyperkinetic circulation during exercise in which oxygen delivery is excessive relative to oxygen uptake and oxygen levels within contracting muscle are abnormally high. To investigate the role of the muscle microcirculation in this anomalous circulatory response and possible implications for the regulation of muscle angiogenesis, we assessed muscle oxidative capacity during cycle exercise and determined capillary levels and distribution and vascular endothelial growth factor expression in quadriceps muscle biopsies in patients with mitochondrial myopathy attributable to heteroplasmic mitochondrial DNA mutations. We found that in patients with mitochondrial myopathy, muscle capillary levels were twice that of sedentary healthy subjects (3.0 ± 0.9% compared with 1.4 ± 0.3%, P < 0.001) despite the fact that oxygen utilization during peak cycle exercise was half that of control subjects (11.1 ± 4.0 ml/kg/min compared with 20.7 ± 7.9 ml/kg/min, P < 0.01); that capillary area was greatest in patients with the most severe muscle oxidative defects and was more than two times higher around muscle fibre segments with defective (i.e. cytochrome oxidase negative/succinic dehydrogenase-positive or 'ragged-red' fibres) compared with more preserved respiratory chain function; and that vascular endothelial growth factor expression paralleled capillary distribution. The increased muscle capillary levels in patients correlated directly (r(2) = 0.68, P < 0.05) with the severity of the mismatch between systemic oxygen delivery (cardiac output) and oxygen utilization during cycle exercise. Our results suggest that capillary growth is increased as a result of impaired muscle oxidative phosphorylation in mitochondrial myopathy, thus promoting increased blood flow to respiration-incompetent muscle fibres and a mismatch between oxygen delivery and utilization during exercise. Furthermore, the finding of high capillary levels despite elevated tissue oxygen levels during exercise in respiration-deficient muscle fibres implies that mitochondrial metabolism activates angiogenesis in skeletal muscle by a mechanism that is independent of hypoxia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232594      PMCID: PMC3267980          DOI: 10.1093/brain/awr293

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  32 in total

Review 1.  Skeletal muscle: microcirculatory adaptation to metabolic demand.

Authors:  R T Hepple
Journal:  Med Sci Sports Exerc       Date:  2000-01       Impact factor: 5.411

Review 2.  Regulation of angiogenesis by hypoxia: role of the HIF system.

Authors:  Christopher W Pugh; Peter J Ratcliffe
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 3.  The diagnosis of mitochondrial muscle disease.

Authors:  Robert W Taylor; Andrew M Schaefer; Martin J Barron; Robert McFarland; Douglass M Turnbull
Journal:  Neuromuscul Disord       Date:  2004-04       Impact factor: 4.296

4.  Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy.

Authors:  S Carpenter; G Karpati; I Heller; A Eisen
Journal:  Neurology       Date:  1978-01       Impact factor: 9.910

5.  Venous oxygen levels during aerobic forearm exercise: An index of impaired oxidative metabolism in mitochondrial myopathy.

Authors:  Tanja Taivassalo; Amy Abbott; Phil Wyrick; Ronald G Haller
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

Review 6.  Muscle structural capacity for oxygen flux from capillary to fiber mitochondria.

Authors:  Odile Mathieu-Costello; Russell T Hepple
Journal:  Exerc Sport Sci Rev       Date:  2002-04       Impact factor: 6.230

7.  Capillary regression in vascular endothelial growth factor-deficient skeletal muscle.

Authors:  Kechun Tang; Ellen C Breen; Hans-Peter Gerber; Napoleone M A Ferrara; Peter D Wagner
Journal:  Physiol Genomics       Date:  2004-06-17       Impact factor: 3.107

8.  The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients.

Authors:  Tanja Taivassalo; Tina Dysgaard Jensen; Nancy Kennaway; Salvatore DiMauro; John Vissing; Ronald G Haller
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

Review 9.  Mitochondrial disorders in the nervous system.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

10.  A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m.7472Cins MTTS1 mutation: are two mutations better than one?

Authors:  Helen Swalwell; Emma L Blakely; Ruth Sutton; Kasia Tonska; Matthias Elstner; Langping He; Tanja Taivassalo; Dennis K Burns; Douglass M Turnbull; Ronald G Haller; Mercy M Davidson; Robert W Taylor
Journal:  Eur J Hum Genet       Date:  2008-04-09       Impact factor: 4.246

View more
  7 in total

1.  Deletion of heart-type cytochrome c oxidase subunit 7a1 impairs skeletal muscle angiogenesis and oxidative phosphorylation.

Authors:  Icksoo Lee; Maik Hüttemann; Jenney Liu; Lawrence I Grossman; Moh H Malek
Journal:  J Physiol       Date:  2012-08-06       Impact factor: 5.182

2.  Knowledge and awareness of mitochondrial diseases among physicians in the tertiary hospitals in Ghana.

Authors:  Eric A Mensah; Bismark Sarfo; Alfred E Yawson; Joshua Arthur; Augustine Ocloo
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 3.  The rise of mitochondria in medicine.

Authors:  Martin Picard; Douglas C Wallace; Yan Burelle
Journal:  Mitochondrion       Date:  2016-07-14       Impact factor: 4.160

4.  Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle.

Authors:  Daniel R Crooks; Thanemozhi G Natarajan; Suh Young Jeong; Chuming Chen; Sun Young Park; Hongzhan Huang; Manik C Ghosh; Wing-Hang Tong; Ronald G Haller; Cathy Wu; Tracey A Rouault
Journal:  Hum Mol Genet       Date:  2013-08-13       Impact factor: 6.150

5.  Metabolic Myopathies: "Human Knockout" Models and Translational Medicine.

Authors:  Bruno Grassi; Simone Porcelli; Mauro Marzorati
Journal:  Front Physiol       Date:  2020-04-30       Impact factor: 4.566

Review 6.  On the dynamic and even reversible nature of Leigh syndrome: Lessons from human imaging and mouse models.

Authors:  Melissa A Walker; Maria Miranda; Amanda Allred; Vamsi K Mootha
Journal:  Curr Opin Neurobiol       Date:  2021-10-14       Impact factor: 7.070

Review 7.  Myopathology of Adult and Paediatric Mitochondrial Diseases.

Authors:  Rahul Phadke
Journal:  J Clin Med       Date:  2017-07-04       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.